28186729|t|N-Terminal Hypothesis for Alzheimer's Disease
28186729|a|Although the amyloid (abeta peptide, Aβ) hypothesis is 25 years old, is the dominant model of Alzheimer's disease (AD) pathogenesis, and guides the development of potential treatments, it is still controversial. One possible reason is a lack of a mechanistic path from the cleavage products of the amyloid precursor protein (APP) such as soluble Aβ monomer and soluble molecular fragments to the deleterious effects on synaptic form and function. From a review of the recent literature and our own published work including aggregation kinetics and structural morphology, Aβ clearance, molecular simulations, long-term potentiation measurements with inhibition binding, and the binding of a commercial monoclonal antibody, aducanumab, we hypothesize that the N-terminal domains of neurotoxic Aβ oligomers are implicated in causing the disease.
28186729	0	10	N-Terminal	T082	UMLS:C1706793
28186729	26	45	Alzheimer's Disease	T038	UMLS:C0002395
28186729	59	66	amyloid	T103	UMLS:C0002716
28186729	68	81	abeta peptide	T103	UMLS:C0078939
28186729	83	85	Aβ	T103	UMLS:C0078939
28186729	131	136	model	T170	UMLS:C3161035
28186729	140	159	Alzheimer's disease	T038	UMLS:C0002395
28186729	161	163	AD	T038	UMLS:C0002395
28186729	165	177	pathogenesis	T038	UMLS:C0699748
28186729	219	229	treatments	T058	UMLS:C0087111
28186729	344	369	amyloid precursor protein	T103	UMLS:C0085151
28186729	371	374	APP	T103	UMLS:C0085151
28186729	465	478	synaptic form	T038	UMLS:C0597545
28186729	521	531	literature	T170	UMLS:C0023866
28186729	544	558	published work	T170	UMLS:C0034036
28186729	594	604	structural	T082	UMLS:C0678594
28186729	617	619	Aβ	T103	UMLS:C0078939
28186729	641	652	simulations	T062	UMLS:C0679083
28186729	654	676	long-term potentiation	T038	UMLS:C0206249
28186729	695	713	inhibition binding	T038	UMLS:C2259198
28186729	723	730	binding	T038	UMLS:C1167622
28186729	747	766	monoclonal antibody	T103	UMLS:C0003250
28186729	768	778	aducanumab	T103	UMLS:C4043101
28186729	804	822	N-terminal domains	T082	UMLS:C1706793
28186729	837	849	Aβ oligomers	T103	UMLS:C0078939
28186729	880	887	disease	T038	UMLS:C0012634